Skip to main content
Top

Journal of Cancer Survivorship

Issue 1/2015

Content (12 Articles)

Neuropathic symptoms, quality of life, and clinician perception of patient care in medical oncology outpatients with colorectal, breast, lung, and prostate cancer

Desiree Jones, Fengmin Zhao, Joanna Brell, Mark A. Lewis, Charles L. Loprinzi, Matthias Weiss, Michael J. Fisch

Open Access

Cancer survivors’ self-efficacy to self-manage in the year following primary treatment

C. Foster, M. Breckons, P. Cotterell, D. Barbosa, L. Calman, J. Corner, D. Fenlon, R. Foster, C. Grimmett, A. Richardson, P. W. Smith

Career readiness in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study

David Strauser, James L. Klosky, Tara M. Brinkman, Alex W. K. Wong, Fong Chan, Jennifer Lanctot, Rohit P. Ojha, Leslie L. Robison, Melissa M. Hudson, Kirsten K. Ness

Long-term workforce participation patterns following head and neck cancer

Alison Pearce, Aileen Timmons, Eleanor O’Sullivan, Pamela Gallagher, Rachael Gooberman-Hill, Audrey Alforque Thomas, Michal Molcho, Phyllis Butow, Linda Sharp

Identifying suicidal symptoms in prostate cancer survivors using brief self-report

Eric S. Zhou, Jim C. Hu, Philip W. Kantoff, Christopher J. Recklitis

Blood pressure, salivary cortisol, and inflammatory cytokine outcomes in senior female cancer survivors enrolled in a tai chi chih randomized controlled trial

Rebecca A. Campo, Kathleen C. Light, Kathleen O’Connor, Yoshio Nakamura, David Lipschitz, Paul C. LaStayo, Lisa M. Pappas, Kenneth M. Boucher, Michael R. Irwin, Harry R. Hill, Thomas B Martins, Neeraj Agarwal, Anita Y. Kinney

Cost-effectiveness of cognitive behavioral therapy and physical exercise for alleviating treatment-induced menopausal symptoms in breast cancer patients

Janne C. Mewes, Lotte M. G. Steuten, Saskia F. A. Duijts, Hester S. A. Oldenburg, Marc van Beurden, Martijn M. Stuiver, Myra S. Hunter, Jacobien M. Kieffer, Wim H. van Harten, Neil K. Aaronson

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine